Agilent Technologies, Inc. (NYSE:A) has been given an average recommendation of “Buy” by the sixteen brokerages that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $67.56.

Several research analysts have recently commented on A shares. Goldman Sachs Group reiterated a “neutral” rating and set a $68.00 target price on shares of Agilent Technologies in a research note on Tuesday, September 26th. Cowen reiterated a “hold” rating and set a $65.00 target price on shares of Agilent Technologies in a research note on Thursday, September 28th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a report on Tuesday, October 10th. Robert W. Baird reissued a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a report on Friday, October 20th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 22,481 shares of Agilent Technologies stock in a transaction on Monday, November 20th. The stock was sold at an average price of $70.00, for a total value of $1,573,670.00. Following the completion of the transaction, the chief executive officer now directly owns 327,882 shares of the company’s stock, valued at approximately $22,951,740. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Didier Hirsch sold 12,964 shares of Agilent Technologies stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $69.00, for a total value of $894,516.00. Following the completion of the transaction, the chief financial officer now directly owns 184,851 shares of the company’s stock, valued at $12,754,719. The disclosure for this sale can be found here. Insiders sold a total of 117,021 shares of company stock valued at $8,128,154 over the last ninety days.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Jennison Associates LLC bought a new position in shares of Agilent Technologies in the 2nd quarter valued at $212,000. Commerce Bank bought a new position in shares of Agilent Technologies in the 2nd quarter valued at $1,242,000. Delta Lloyd Asset Management N.V. bought a new position in shares of Agilent Technologies in the 2nd quarter valued at $2,026,000. Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Agilent Technologies by 9.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock valued at $64,086,000 after purchasing an additional 90,317 shares during the last quarter. Finally, Prudential Financial Inc. increased its stake in shares of Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock valued at $27,134,000 after purchasing an additional 11,020 shares during the last quarter.

Shares of Agilent Technologies (NYSE A) traded down $0.17 during midday trading on Friday, hitting $66.51. The stock had a trading volume of 1,774,500 shares, compared to its average volume of 1,869,982. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85. Agilent Technologies has a one year low of $45.36 and a one year high of $70.93. The company has a market cap of $21,459.49, a P/E ratio of 28.14, a P/E/G ratio of 2.02 and a beta of 1.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the company posted $0.59 EPS. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. equities analysts predict that Agilent Technologies will post 2.58 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be issued a dividend of $0.149 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.24%.

ILLEGAL ACTIVITY NOTICE: “Agilent Technologies, Inc. (A) Receives Average Rating of “Buy” from Analysts” was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.dailypolitical.com/2017/12/15/agilent-technologies-inc-a-receives-average-rating-of-buy-from-analysts.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.